Follow us

2021_

VON LOCQUENGHIEN M, ROZALÉN C, CELIÀ-TERRASSA T

Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response. The Journal of Clinical Investigation 2021.

View publication_

2019_

Celià-Terrassa T*, Jolly MK.

Cancer stem cells and epithelial-to-mesenchymal transition in cancer metastasis. Review in Cold Spring Harbor Perspectives in Medicine.

View publication_
Jolly MK., Celià-Terrassa T*.

Dynamics of phenotypic heterogeneity associated with EMT and stemness during cancer progression. Review in Journal of Clinical Medicine.

View publication_
Shen M, Jiang YZ, Wei Y, Ell B, Sheng X, Esposito M, Kang J, Hang X, Zheng H, Rowicki M, Zhang L, Shih WJ, Celià-Terrassa T, Liu Y, Cristea I, Shao ZM, Kang Y.

Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling. Cancer Cell.

View publication_

2018_

Celià-Terrassa T*, Bastian C*, Liu D. D, Ell B, Aiello N, Wei Y, Zamalloa J, Blanco A. M, Hang X, Kunisky D, Rabitz H and Kang Y

Hysteresis control of epithelial-mesenchymal transition dynamics conveys a distinct program with enhanced metastatic ability. Nature Communications.

View publication_
Celià-Terrassa T, Kang Y.

Metastatic niche functions and therapeutic opportunities. Nature Cell Biology

View publication_
Chakrabarti R, Celià-Terrassa T, Kumar S, Hang X, Wei Y, Choudhury A, Hwang J, Peng J, Nixon B, Grady J, DeCoste C, Gao J, Van Es J, Li MO, Aifantis I, Clevers H, Kang Y.

Notch ligand Dll1-mediated crosstalk between mammary gland stem cells and the macrophageal niche. Science

View publication_
Celià-Terrassa T

Mammary stem cells and breast cancer stem cells: molecular connections and clinical implications. (2018) May 4 Biomedicines

View publication_

2017_

Celià-Terrassa T, Liu D, Choudhury A, Hang X, Wei Y, Zamalloa J, Alfaro-Aco R, Chakrabarti R, Jiang Y, Ihn Koh B, Smith H, DeCoste C, Li J, Shao Z and Kang Y.

Normal and cancer mammary stem cells evade interferon-induced constraint through the miR-199a-LCOR axis. Nature Cell Biology (Cover highlighted)

View publication_

2016_

Celià-Terrassa T, Kang Y.

Distinctive properties of metastasis-initiating cells. 30(8). Genes & Development

View publication_

2012_

Celià-Terrassa T, Meca-Cortés O, Mateo F, Martínez de Paz A, Rubio N, Arnal-Estapé A, Ell BJ, Bermudo R, Díaz A, Guerra-Rebollo M, Lozano JJ, Estarás C, Ulloa C, Álvarez-Simón D, Milà J, Vilella R, Paciucci R, Martínez-Balbás M, García de Herreros A, Gomis R, Kang Y, Blanco J, Fernández PL, and Thomson TM.

Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor- initiating cells. Journal of Clinical Investigation

View publication_

2011_

Korpal M, Ell BJ, Buffa FM, Ibrahim T, Blanco MA, Celià-Terrassa T, Mercatali L, Khan Z, Goodarzi H, Hua Y, Wei Y, Hu G, Garcia B, Ragoussis J, Amadori D, Harris AL and Kang Y.

Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. 17:1101-1108. Nature Medicine

View publication_

INTERESTED TO COOPERATE WITH US? MAKE YOUR DONATION

Celià-Terrassa Lab

The Celià-Terrassa’s Lab started in January 2018 and focuses on understanding the complexity and dynamics of metastasis, in particular the molecular mechanisms regulating breast cancer stem cells (bCSCs) and their interplay with the metastatic niche. We are interested on studying the molecular mechanisms underlying Cancer Stem Cell (CSC) cellular plasticity leading tumor progression, chemorresistance and relapse, as a major challenge to efficiently target breast cancer metastasis.